Malin Life Sciences Holdings Ltd 4
4 · Poseida Therapeutics, Inc. · Filed Dec 2, 2021
Insider Transaction Report
Form 4
Malin Life Sciences Holdings Ltd
10% Owner
Transactions
- Purchase
COMMON STOCK
2021-11-30$6.85/sh+28,592$195,838→ 9,661,184 total - Purchase
COMMON STOCK
2021-12-01$6.85/sh+18,365$125,806→ 9,679,549 total - Purchase
COMMON STOCK
2021-12-02$6.88/sh+4,296$29,550→ 9,683,845 total
Footnotes (1)
- [F1]The reported prices in Column 4 are weighted average prices. Those shares were purchased in multiple transactions at per share prices ranging from $6.70 to $6.95 on 11/30/2021; $6.80 to $6.90 on 12/01/2021; and $6.82 to $6.90 on 12/02/2021. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.